Inbiome

D-Nome

This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.

iFAST Diagnositcs

The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.

Resistell

This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.

Biome Diagnostics

This company develops AI-powered microbiome diagnostic tools and cancer immunotherapy prediction tests for healthcare professionals, laboratories, and individual consumers.

Human Biome

This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

MeMed

MeMed develops machine learning diagnostic tests that distinguish between bacterial and viral infections to assist clinicians in making treatment and antibiotic decisions.

Insentio

The company develops artificial intelligence technology for the rapid identification of infectious bacteria to assist healthcare providers and laboratories.